South African executive scores big with $55-million gain from Aspen Pharmacare
South African executive Michael Guy Attridge (Gus Attridge) has witnessed a remarkable year-to-date gain of more than $55 million from his stake in Aspen Pharmacare
Gus Attridge
Gus Attridge gains $55 million from investment in Aspen
Attridge, Aspen’s group chief advisor who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharma company.
South African exec Gus Attridge loses $10 million in 13 days from stake in Aspen Pharmacare
Attridge owns a 4.26-percent stake in the company.
South African multimillionaire Gus Attridge’s stake in Aspen now worth $171 million
Aspen Pharmacare is a multinational pharmaceutical holding company.